Invenra has entered a collaboration with Merck to discover fully human therapeutic antibodies against an unnamed target of interest to Merck. “We are excited to be working with this first rate team in Merck,” said Roland Green, chief executive officer, Invenra.  “Invenra’s ability to test antibodies for a functional phenotype early in the screening process combined with Merck’s established role as a leader in this field will advance the science regarding difficul...